Expertise in
10
conditions

Manabu Shiozawa

Yokohama, JP 
Expertise in
10
conditions
Yokohama, JP 

Overview

Manabu Shiozawa practices practicing medicine in Yokohama, Japan.

Mr. Shiozawa is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 255 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Yokohama, Japan
Other Locations
Kanagawa, Japan
Tokyo, Japan
Gifu-shi, 5061205, Japan
Technology Strategy Div, Toranomon Hills, 1-17-1 Minato Ku, Toranomon, 1056409, Japan
Nakao, 2418515, Japan
Osaka, Japan
Kokubunji, 1858601, Japan
Kashiwa, 2778582, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
Enrollment Status: Completed
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drugs: Trifluridine, Tipiracil
Study Phase: Phase 3

254 Total Publications

Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026

Frequently Asked Questions about Manabu Shiozawa

Is Manabu Shiozawa a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Manabu Shiozawa is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Manabu Shiozawa participate in research or clinical trials?

Yes. Manabu Shiozawa has published 254 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Manabu Shiozawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Shiozawa's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile